Role of Specific microRNAs in Cluster Headache

Recruiting Observational Study
Cluster Headache
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 65
Sex
Any
Study type
Observational
Participants needed
100 (estimated)
Sponsor
IRCCS National Neurological Institute "C. Mondino" Foundation · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Cluster headache (CH) is a primary headache included in the trigeminal autonomic cephalalgias (TACs) according to the International Calssification of Headache Disorder, Third Edition. CH is characterized by a multifaceted and incompletely understood pathophysiology. Recent experimental evidence has increasingly emphasized the role of specific microRNAs (miRNAs) in the pathophysiology of primary he…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
\- Healthy Controls Inclusion Criteria: * age between \>18 and \<65 years Exclusion Criteria: * diagnosis of primary and/or secondary headache according to ICHD-III criteria (only diagnosis of sporadic tension type headache is allowed) * diagnosis of neurological disorders * diagnosis of medical…
Contacts

Roberto De Icco, MD, PhD

00390382380387

roberto.deicco@mondino.it

CONTACT

Francescantonio Cammarota, MD

00390382380387

francesco.cammarota@mondino.it

CONTACT